Clear Street LLC reports 12.8% stake in Ernexa (NASDAQ: ERNA)

Rhea-AI Filing Summary

Ernexa Therapeutics Inc. disclosed a Schedule 13G showing Clear Street LLC beneficially owns 149,499 shares of Common Stock, representing 12.8% of the class as of 05/05/2026.

The filing reports sole voting and sole dispositive power over the 149,499 shares. The filing is signed by John DiBacco, Head of Markets Trading for Clear Street LLC.

Insights

Institutional Ownership Analyst

Large passive stake disclosed by a market participant.

The Schedule 13G lists Clear Street LLC as beneficial owner of 12.8% of common stock with sole voting and dispositive power over 149,499 shares as of 05/05/2026. This indicates a material institutional holding disclosed under beneficial-ownership rules.

Dependence: the filing shows ownership and voting power only; it does not state acquisition method or intent. Subsequent filings may clarify any changes in position or voting arrangements.

Corporate Governance Specialist

Filing clarifies control rights tied to the disclosed stake.

The filing reports sole voting power and sole dispositive power149,499 shares, which is the dispositive authority the filing attributes to Clear Street LLC. That allocation is important for vote-counting on corporate matters.

Investor implications depend on whether Clear Street exercises voting rights; the Schedule 13G itself does not state any planned votes or agreements.

Key Figures

Shares owned: 149,499 shares Percent of class: 12.8% CUSIP: 114082407 +1 more

4 metrics

Shares owned 149,499 shares Beneficial ownership as of <date>05/05/2026</date>

Percent of class 12.8% Percent of common stock class reported in Schedule 13G

CUSIP 114082407 Ernexa Therapeutics Inc. Common Stock CUSIP

Filing date 05/05/2026 Date of signature on Schedule 13G

Key Terms

Schedule 13G, Beneficially owned, Sole Voting Power, Sole Dispositive Power

4 terms

Schedule 13G regulatory

"disclosed a Schedule 13G showing Clear Street LLC beneficially owns"

A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

Beneficially owned financial

"Amount beneficially owned: 149499 (b) Percent of class: 12.8 %"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

Sole Voting Power corporate

"Sole Voting Power 149,499.00"

Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.

Sole Dispositive Power corporate

"Sole power to dispose or to direct the disposition of: 149499"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/14/2026 - 12:31 PM Learn about SEC filing dates

FAQ

Who filed the Schedule 13G for ERNA?

Clear Street LLC filed the Schedule 13G. The filing lists Clear Street LLC as the beneficial owner and is signed by John DiBacco, Head of Markets Trading.

How many Ernexa (ERNA) shares does Clear Street LLC own?

Clear Street LLC beneficially owns 149,499 shares of Ernexa common stock. The filing states this equals 12.8% of the class as of 05/05/2026.

What voting and dispositive powers are reported in the ERNA filing?

The Schedule 13G reports Clear Street LLC has sole voting power and sole dispositive power over 149,499 shares. Shared voting and dispositive powers are reported as 0.

What date does the Ernexa Schedule 13G ownership reflect?

The ownership information in the Schedule 13G is dated 05/05/2026. That date is shown beside the signature from Clear Street LLC's representative.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Ernexa Therapeutics Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

114082407

(CUSIP Number)

05/05/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 114082407

1

Names of Reporting Persons

Clear Street LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

NEW YORK

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 149,499.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

149,499.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

12.8 %

12

Type of Reporting Person (See Instructions)

BD

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Ernexa Therapeutics Inc.
(b)	Address of issuer's principal executive offices: 1035 Cambridge Street Suite 18A Cambridge MA 02141
Item 2.
(a)	Name of person filing: Clear Street LLC
(b)	Address or principal business office or, if none, residence: 4 WORLD TRADE CENTER, 150 Greenwich St Floor 45 New York, NY 10007
(c)	Citizenship: United States
(d)	Title of class of securities: Common Stock
(e)	CUSIP Number(s): 114082407
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 149499
(b)	Percent of class: 12.8 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 149499
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 149499
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10. Certifications:

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Clear Street LLC

Signature:	John DiBacco
Name/Title:	Head of Markets Trading
Date:	05/05/2026